Skip to main content
Premium Trial:

Request an Annual Quote

Zoetis to Incorporate Eureka Genotyping Tech into Animal Genetics Products

NEW YORK (GenomeWeb) – Eureka Genomics today announced an agreement with animal health firm Zoetis for use of Eureka's next-generation genotyping technology in its products.

Zoetis will use Eureka's technology — which combines high-throughput genetic sequencing and proprietary DNA processing and computing solutions — for its cattle and sheep genetics business. As part of the deal, Florham Park, NJ-based Zoetis has obtained the rights to incorporate the technology into existing and new products. It also has options to distribute products already developed by Eureka.

Eureka is exclusively providing Zoetis certain next-generation genotyping services and the firms will partner on new product development, Eureka said. While distribution options are being reviewed, Eureka will continue working with existing customers, the Hercules, Calif.-based firm added.

Zoetis Global Head of Genetics Jon Lowe said in a statement that Eureka's next-generation genotyping service will "replace some of our current genotyping platforms and provide opportunities for the development of new products and services."

Financial and other terms of the deal were not disclosed.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.